The Vietnamese pharmaceutical industry is entering a highly strategic transitional phase, shifting aggressively from traditional competitive parameters — such as... Read more
Category: Uncategorized
Effective July 10, 2026: Healthcare facilities mandated to ensure absolute transparency in free drug programs
The Ministry of Health of Vietnam has officially promulgated Circular No. 16/2026/TT-BYT, establishing strict regulatory operations for implementing free medication... Read more
Vietnam’s Ministry of Health issues new Circular governing free drug programs, strictly prohibiting advertising exploitation
The Permanent Vice Minister of Health has officially signed into effect a comprehensive Circular outlining strict regulatory requirements for implementing... Read more
Government issues new Decree tightening licensing protocols for regulated narcotic and precursor activities
The Government of Vietnam has officially promulgated Decree No. 163/2026/ND-CP, providing detailed regulations and guidelines for implementing specific articles of... Read more
Deputy Minister of Health Nguyen Tri Thuc: Technology must serve as ‘wings’ for children’s development
On May 27, the Ministry of Health, in coordination with the People's Committee of Quang Ninh Province, officially launched the... Read more
Pharmacity secures new funding from LeapFrog, targeting 500 new store openings over 3 years
Modern pharmacy retail chain Pharmacity has finalized a definitive funding round with international impact investor LeapFrog Investments, marking a new... Read more
Gilead’s Hepcludex captures US FDA accelerated approval as pioneering hepatitis D therapy
The United States Food and Drug Administration (FDA) has granted formal accelerated approval to Gilead Sciences’ proprietary therapeutic asset, Hepcludex... Read more
US FDA extends review window for AstraZeneca’s breast cancer candidate to evaluate supplementary datasets
Multinational pharmaceutical flagship AstraZeneca announced on Wednesday that the U.S. Food and Drug Administration (FDA) has formally extended its regulatory... Read more
Eli Lilly deploys nearly $4 billion to acquire three vaccine developers in infectious disease push
U.S. pharmaceutical heavyweight Eli Lilly has announced definitive agreements to purchase three clinical-stage vaccine developers in multi-lateral transactions valued at... Read more








